🇺🇸 FDA
Pipeline program

Either normal nicotine content cigarettes (15.8mg/g) or reduced nicotine content cigarettes (0.4mg/g)

CHRMS19-0129

Phase 2 other completed

Quick answer

Either normal nicotine content cigarettes (15.8mg/g) or reduced nicotine content cigarettes (0.4mg/g) for Tobacco Use Disorder is a Phase 2 program (other) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Tobacco Use Disorder
Phase
Phase 2
Modality
other
Status
completed

Clinical trials